Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material (Q38484655)

3 September 2017

Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material (English)

1 reference

3 September 2017

0 references

1 reference

E Karamitopoulou

1

1 reference

3 September 2017

E Perentes

series ordinal

2

1 reference

3 September 2017

I Diamantis

series ordinal

3

1 reference

3 September 2017

T Maraziotis

series ordinal

4

1 reference

3 September 2017

1 January 1994

1 reference

3 September 2017

Acta Neuropathologica

1 reference

3 September 2017

87

1 reference

3 September 2017

1

1 reference

3 September 2017

47-54

1 reference

Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics

3 September 2017

1 reference

12 December 2020

The implications of the heterogeneous distribution of Ki-67 labelled cells in meningiomas

1 reference

12 December 2020

The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours.

1 reference

12 December 2020

The new WHO classification of brain tumours

1 reference

12 December 2020

The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology

1 reference

12 December 2020

Immunohistochemical demonstration of the KI-67-antigen in paraffin-embedded tumor biopsies

1 reference

12 December 2020

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1 reference

12 December 2020

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

12 December 2020

Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations

1 reference

12 December 2020

Oligodendrogliomas: the Mayo Clinic experience

1 reference

12 December 2020

The proliferation rate of intracranial tumors as defined by the monoclonal antibody KI 67. Application of the method to paraffin embedded specimens.

1 reference

12 December 2020

Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence

1 reference

12 December 2020

Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast

1 reference

12 December 2020

Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.

1 reference

12 December 2020

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study

1 reference

12 December 2020

The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material

1 reference

12 December 2020

Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity

1 reference

12 December 2020

Immunohistochemical markers of cellular proliferation: achievements, problems and prospects

1 reference

12 December 2020

In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.

1 reference

12 December 2020

Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases.

1 reference

12 December 2020

Cell kinetic analyses of human malignant brain tumors (gliomas)

1 reference

12 December 2020

Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67

1 reference

12 December 2020

Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67

1 reference

12 December 2020

Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignancy and proliferation indices.

1 reference

12 December 2020

Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms

1 reference

12 December 2020

Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study

1 reference

12 December 2020

Immunocytochemical staining of proliferating cells in endoscopically biopsied tissues of gastric carcinomas with monoclonal antibody Ki-67.

1 reference

12 December 2020

Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.

1 reference

12 December 2020

The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.

1 reference

12 December 2020

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

12 December 2020

Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumors.

1 reference

12 December 2020

Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67.

1 reference

12 December 2020

Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.

1 reference

12 December 2020

Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination.

1 reference

12 December 2020

Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors

1 reference

12 December 2020

Cell kinetics studies of human brain tumors by in vitro labeling using anti-BUdR monoclonal antibody

1 reference

12 December 2020

In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.

1 reference

12 December 2020

Prognostic implications of the bromodeoxyuridine labeling index of human gliomas

1 reference

12 December 2020

Clinicopathologic correlations in the oligodendroglioma.

1 reference

12 December 2020

Proliferating cell nuclear antigen expression in central nervous system neoplasms.

1 reference

12 December 2020

The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma

1 reference

12 December 2020

Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours.

1 reference

12 December 2020

Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

1 reference

12 December 2020

Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine.

1 reference

12 December 2020

Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nuclear organizer region counts.

1 reference

12 December 2020

Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67

1 reference

12 December 2020

Identifiers

DOI

10.1007/S004010050055

1 reference

3 September 2017

1 reference